The company filed for the resale by selling stockholders of up to 1.68M shares of common stock, issuable upon the exercise of outstanding warrants issued on May 30. No underwriter or other person has been engaged to facilitate the sale of the common stock in this offering
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BSGM:
- BioSig Technologies Announces CFO Transition and New Appointment
- BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer
- BioSig Technologies appoints Ferdinand Groenewald to interim CFO
- BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- BioSig Technologies prices 1.57M shares at $1.91 in registered direct offering